Literature DB >> 20832556

Safety and effectiveness of intensive insulin protocol use in post-operative liver transplant recipients.

M T Keegan1, J M Vrchota, P M Haala, J V Timm.   

Abstract

There is a paucity of data regarding the safety and utility of strict glycemic control in patients undergoing orthotopic liver transplantation (OLT). Although control of hyperglycemia may theoretically be beneficial, concerns exist regarding the effect of iatrogenic hypoglycemia on graft function. We performed a retrospective observational study evaluating the impact of the introduction of a nurse-initiated glycemic control protocol on OLT recipients cared for in a single intensive care unit (ICU). The medical records of 84 OLT recipients in 2003 (Preprotocol group) and 77 recipients in 2007 (Protocol group) were reviewed. Data regarding demographics, medical history, physiology, perioperative anesthesia and surgical events, ICU stay, graft function, and mortality were abstracted. Glucose values on admission to ICU, at 2, 6, 12, 18, and 24 hours after surgery, and at 4 am on the morning after OLT were recorded. Patients in the Protocol group achieved better and faster glycemic control. The odds ratio for severe hyperglycemia (glucose >250 mg/dL) in the Protocol group was 0.16 (95% confidence interval, 0.09-0.28). Hypoglycemia was not observed. The 1-year mortality was 5.3% in the Preprotocol and 6.0% in the Protocol group (P = .86). The rate of graft loss was low, and there was no difference in the incidence of graft failure between the Preprotocol and Protocol groups. We conclude that nurse-initiated and -directed glycemic control protocols can be safely and effectively used in the early period after OLT, though we did not identify a beneficial effect on graft function.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832556     DOI: 10.1016/j.transproceed.2010.05.156

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years.

Authors:  A Ramos-Prol; D Hervás-Marín; B Rodríguez-Medina; M Rubio-Almanza; M Berenguer; Á Moya-Herraiz; J F Merino-Torres
Journal:  J Endocrinol Invest       Date:  2017-12-30       Impact factor: 4.256

2.  Bolus versus continuous insulin infusion in immediate postoperative blood glucose control in liver transplantation: pragmatic clinical trial.

Authors:  Luciana Vládia Carvalhêdo Fragoso; Márcio Flávio Moura de Araújo; Lidianne Fernandes da Silva Lobo; Dirk Schreen; Maria Lúcia Zanetti; Marta Maria Coelho Damasceno
Journal:  Einstein (Sao Paulo)       Date:  2022-06-01

Review 3.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

Review 4.  Hyperglycemia and Diabetes Mellitus Following Organ Transplantation.

Authors:  Rodolfo J Galindo; Amisha Wallia
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

5.  The impact of post-transplant diabetes mellitus on liver transplant outcomes.

Authors:  Sarah R Lieber; Ruth-Ann Lee; Yue Jiang; Claire Reuter; Randall Watkins; Kristen Szempruch; David A Gerber; Chirag S Desai; G Stephen DeCherney; A Sidney Barritt
Journal:  Clin Transplant       Date:  2019-04-23       Impact factor: 3.456

Review 6.  Management of the hospitalized transplant patient.

Authors:  Brian Boerner; Vijay Shivaswamy; Whitney Goldner; Jennifer Larsen
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

7.  Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review.

Authors:  Prani Paka; Sarah R Lieber; Ruth-Ann Lee; Chirag S Desai; Robert E Dupuis; Alfred Sidney Barritt
Journal:  World J Transplant       Date:  2018-06-28

Review 8.  Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment.

Authors:  Maria J Peláez-Jaramillo; Allison A Cárdenas-Mojica; Paula V Gaete; Carlos O Mendivil
Journal:  Diabetes Ther       Date:  2018-02-06       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.